Amrik S Basi, MD
Emergency Medicine · Modesto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
- Since medical school
- 28 years
- Graduated 1998
Offices
1 location
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Basi’s office at (209) 846-3176 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A92203 · Current
Licensed to practise in California · since 2005 · expires 2027-01-31 · Punjab University, Dayanand Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Family Medicine - Family Medicine
Original Medicare doctor bills
$88,766
Medicare paid this office $88,766 for 371 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 74 | $23,595 | $143 |
| Return visit (30+ min) | 100 | $11,791 | $90 |
| Short return visit (20+ min) | 130 | $11,212 | $59 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 72 | $8,514 | $52 |
| New patient visit (60+ min) | 56 | $7,737 | $138 |
See all 20 services
| Long return visit (40+ min) | 74 | $23,595 | $143 |
| Return visit (30+ min) | 100 | $11,791 | $90 |
| Short return visit (20+ min) | 130 | $11,212 | $59 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 72 | $8,514 | $52 |
| New patient visit (60+ min) | 56 | $7,737 | $138 |
| New patient visit (45+ min) | 61 | $6,174 | $101 |
| New patient visit (30+ min) | 73 | $4,850 | $66 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 56 | $2,967 | $50 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 141 | $1,659 | $8 |
| Detection test by immunoassay with direct visual observation for influenza virus | 52 | $957 | $16 |
| Injection of drug or substance under skin or into muscle | 70 | $825 | $10 |
| Insertion of needle into vein for collection of blood sample | 62 | $465 | $6 |
| Injection, ceftriaxone sodium, per 250 mg | 51 | $289 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 66 | $257 | None |
| Blood test, comprehensive group of blood chemicals | 20 | $238 | $10 |
| Urinalysis, manual test | 56 | $235 | $3 |
| Automated urinalysis test | 31 | $79 | $2 |
| Infusion, normal saline solution, 250 cc | 32 | $39 | None |
| Injection, ketorolac tromethamine, per 15 mg | 21 | $37 | None |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 27 | $34 | None |
Procedures Medicare counted
| Removal of nail tissue | 1-10 | None |
| Removal of tissue | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Aspiration and/or injection of fluid from large joint | – | – | 15 | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
371 Original Medicare patients in 2024. Average age 73 · Under 65 7% · 85 and older 9% · Women 67% · Also on Medicaid 14% · Health risk score 0.94. At or below the middle of the specialty; the typical emergency medicine clinician is at 2.01.
Conditions among them: High blood pressure 71% · Diabetes 31% · Coronary heart disease 20% · Chronic kidney disease 20% · Depression 20% · Atrial fibrillation 18% · Cancer 10% · COPD 10% · Heart failure 9% · Stroke 8% · Dementia 4%.
The office billed $246,469, Medicare allowed $123,215 and paid $88,766; for 3,799 services of 67 kinds; $814 of it was for drugs given in the office and $87,952 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 371 | 3,799 | 73 | 0.94 | $246,469 | $88,766 |
| 2023 | 439 | 3,365 | 73 | 1.06 | $249,986 | $89,742 |
| 2022 | 737 | 4,234 | 72 | 1.11 | $549,839 | $283,525 |
| 2021 | 562 | 4,049 | 71 | 0.89 | $366,744 | $167,351 |
| 2020 | 300 | 2,700 | 72 | 1.14 | $166,739 | $51,845 |
| 2019 | 363 | 3,360 | 72 | 1.15 | $236,745 | $75,202 |
| 2018 | 292 | 3,916 | 71 | 1.17 | $184,772 | $61,488 |
| 2017 | 375 | 3,858 | 69 | 1.21 | $234,396 | $73,030 |
| 2016 | 300 | 2,613 | 71 | 1.11 | $186,145 | $67,199 |
| 2015 | 89 | 513 | 70 | 1.39 | $44,140 | $21,134 |
| 2013 | 33 | 35 | 64 | 1.18 | $8,785 | $1,662 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 22 services
| Short return visit (20+ min) | 194 | $16,032 | $61 |
| Long return visit (40+ min) | 67 | $14,484 | $138 |
| Return visit (30+ min) | 89 | $11,583 | $91 |
| New patient visit (45+ min) | 80 | $8,897 | $111 |
| New patient visit (30+ min) | 116 | $8,461 | $73 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 68 | $6,393 | $52 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 96 | $5,279 | $50 |
| New patient visit (60+ min) | 34 | $5,181 | $152 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 194 | $2,192 | $8 |
| Injection of drug or substance under skin or into muscle | 97 | $1,094 | $10 |
| Detection test by immunoassay technique for influenza virus | 37 | $526 | $14 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 99 | $453 | None |
| Urinalysis, manual test | 83 | $355 | $3 |
| Insertion of needle into vein for collection of blood sample | 52 | $341 | $6 |
| Injection, ceftriaxone sodium, per 250 mg | 56 | $288 | None |
| Blood test, comprehensive group of blood chemicals | 17 | $186 | $10 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 16 | $142 | $9 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 12 | $137 | None |
| Automated urinalysis test | 30 | $81 | $2 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 39 | $58 | None |
| Injection, ketorolac tromethamine, per 15 mg | 20 | $35 | None |
| Infusion, normal saline solution, 250 cc | 37 | $29 | None |
2022: 26 services
| Intravenous injection, bebtelovimab, includes injection and post administration monitoring | 200 | $69,886 | $344 |
| New patient visit (60+ min) | 296 | $43,658 | $147 |
| Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | 67 | $29,790 | $445 |
| Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | 60 | $24,000 | $400 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 307 | $22,236 | $56 |
| Short return visit (20+ min) | 199 | $20,451 | $67 |
| Return visit (30+ min) | 103 | $16,460 | $96 |
| New patient visit (45+ min) | 120 | $14,711 | $123 |
| Long return visit (40+ min) | 46 | $8,827 | $145 |
| New patient visit (30+ min) | 121 | $8,665 | $72 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 111 | $6,795 | $51 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 151 | $1,782 | $8 |
| Short return visit | 27 | $1,207 | $42 |
| Injection of drug or substance under skin or into muscle | 71 | $1,001 | $11 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 58 | $329 | None |
| Injection, ceftriaxone sodium, per 250 mg | 49 | $285 | None |
| Urinalysis, manual test | 56 | $240 | $3 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 25 | $198 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 14 | $153 | $11 |
| Insertion of needle into vein for collection of blood sample | 42 | $151 | $3 |
| Blood test, comprehensive group of blood chemicals | 11 | $146 | $10 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 51 | $90 | None |
| Infusion, normal saline solution, 250 cc | 86 | $59 | None |
| Automated urinalysis test | 23 | $56 | $2 |
| Injection, ketorolac tromethamine, per 15 mg | 20 | $44 | None |
| Injection, bebtelovimab, 175 mg | 104 | $6 | $0 |
2021: 31 services
| Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | 76 | $30,800 | $400 |
| Return visit (30+ min) | 92 | $21,258 | $103 |
| Short return visit (20+ min) | 173 | $20,902 | $69 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 176 | $18,495 | $61 |
| New patient visit (30+ min) | 202 | $15,246 | $75 |
| Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 35 | $14,000 | $400 |
| New patient visit (60+ min) | 77 | $13,209 | $172 |
| New patient visit (45+ min) | 74 | $8,916 | $120 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 102 | $6,003 | $51 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, dna, spike protein, adenovirus type 26 (ad26) vector, preservative free, 5x1010 viral particles/0.5ml dosage; single dose | 43 | $1,726 | $40 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 114 | $1,686 | $8 |
| Long return visit (40+ min) | 13 | $1,434 | $110 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; first dose | 23 | $939 | $41 |
| Aspiration and/or injection of fluid from large joint | 13 | $738 | $49 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; second dose | 16 | $670 | $42 |
| Injection of drug or substance under skin or into muscle | 42 | $511 | $11 |
| Injection, ceftriaxone sodium, per 250 mg | 51 | $393 | None |
| Blood test, comprehensive group of blood chemicals | 29 | $338 | $11 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 48 | $284 | None |
| Urinalysis, manual test | 57 | $251 | $3 |
| Insertion of needle into vein for collection of blood sample | 57 | $231 | $3 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 19 | $222 | $11 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 16 | $189 | None |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 66 | $162 | None |
| Infusion, normal saline solution, 250 cc | 125 | $82 | None |
| Infusion, normal saline solution , 1000 cc | 15 | $37 | None |
| Automated urinalysis test | 14 | $34 | $2 |
| Injection, ketorolac tromethamine, per 15 mg | 11 | $17 | None |
| Injection, ondansetron hydrochloride, per 1 mg | 14 | $9 | None |
| Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, dna, spike protein, adenovirus type 26 (ad26) vector, preservative free, 5x1010 viral particles/0.5ml dosage, for intramuscular use | 46 | $0 | $0 |
| Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage, for intramuscular use | 23 | $0 | $0 |
2020: 18 services
| Short return visit (20+ min) | 140 | $13,323 | $51 |
| New patient visit (30+ min) | 143 | $9,970 | $70 |
| Return visit (30+ min) | 61 | $8,730 | $82 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 51 | $6,592 | $57 |
| New patient visit (45+ min) | 29 | $3,048 | $105 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 128 | $1,494 | $8 |
| Injection of drug or substance under skin or into muscle | 71 | $644 | $8 |
| Blood test, comprehensive group of blood chemicals | 42 | $630 | $11 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 18 | $304 | $13 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 55 | $288 | None |
| Injection, ceftriaxone sodium, per 250 mg | 32 | $203 | None |
| Urinalysis, manual test | 45 | $198 | $3 |
| Insertion of needle into vein for collection of blood sample | 34 | $146 | $3 |
| Injection, ketorolac tromethamine, per 15 mg | 44 | $94 | None |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 44 | $88 | None |
| Automated urinalysis test | 23 | $56 | $2 |
| Infusion, normal saline solution, 250 cc | 16 | $15 | None |
| Injection, ondansetron hydrochloride, per 1 mg | 17 | $11 | None |
2019: 25 services
| Short return visit (20+ min) | 191 | $21,645 | $55 |
| New patient visit (30+ min) | 179 | $12,988 | $73 |
| Return visit (30+ min) | 65 | $11,798 | $86 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 63 | $8,599 | $60 |
| New patient visit (45+ min) | 48 | $5,434 | $113 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 197 | $2,699 | $8 |
| Blood test, comprehensive group of blood chemicals | 77 | $1,358 | $12 |
| Injection of drug or substance under skin or into muscle | 81 | $1,058 | $12 |
| Infusion into a vein for hydration, 31-60 minutes | 22 | $899 | $32 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 32 | $428 | $13 |
| Injection, ceftriaxone sodium, per 250 mg | 54 | $335 | None |
| Inhalation treatment for airway obstruction or sputum production | 21 | $328 | $14 |
| Urinalysis, manual test | 74 | $327 | $3 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 60 | $191 | None |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 12 | $85 | None |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 52 | $84 | None |
| Manual urinalysis test with examination using microscope, non-automated | 20 | $79 | $4 |
| Insertion of needle into vein for collection of blood sample | 23 | $74 | $3 |
| Injection, ketorolac tromethamine, per 15 mg | 35 | $64 | None |
| Infusion, normal saline solution, 250 cc | 36 | $37 | None |
| Infusion, normal saline solution , 1000 cc | 14 | $33 | None |
| Automated urinalysis test | 13 | $32 | $2 |
| Injection, ondansetron hydrochloride, per 1 mg | 18 | $15 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 13 | $5 | None |
| Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 24 | $3 | None |
2018: 22 services
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 78 | $10,430 | $61 |
| Short return visit (20+ min) | 109 | $10,097 | $55 |
| Return visit (30+ min) | 62 | $9,947 | $84 |
| New patient visit (30+ min) | 108 | $8,030 | $74 |
| New patient visit (45+ min) | 59 | $6,797 | $115 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 187 | $2,811 | $9 |
| Blood test, comprehensive group of blood chemicals | 75 | $1,457 | $13 |
| Injection of drug or substance under skin or into muscle | 90 | $1,338 | $13 |
| Insertion of needle into vein for collection of blood sample | 137 | $609 | $3 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 27 | $476 | $14 |
| Inhalation treatment for airway obstruction or sputum production | 31 | $471 | $13 |
| Injection, ceftriaxone sodium, per 250 mg | 68 | $391 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 74 | $385 | None |
| Urinalysis, manual test | 75 | $321 | $3 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 11 | $113 | None |
| Injection, ketorolac tromethamine, per 15 mg | 57 | $111 | None |
| Automated urinalysis test | 29 | $98 | $3 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 38 | $56 | None |
| Infusion, normal saline solution, 250 cc | 45 | $38 | None |
| Infusion, normal saline solution , 1000 cc | 18 | $36 | None |
| Injection, ondansetron hydrochloride, per 1 mg | 47 | $34 | None |
| Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 26 | $3 | None |
2017: 25 services
| Short return visit (20+ min) | 147 | $16,617 | $50 |
| New patient visit (30+ min) | 224 | $14,455 | $65 |
| Return visit (30+ min) | 59 | $7,670 | $80 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 61 | $6,739 | $56 |
| New patient visit (45+ min) | 52 | $5,483 | $105 |
| Infusion into a vein for hydration, 31-60 minutes | 53 | $5,229 | $45 |
| Injection of drug or substance under skin or into muscle | 103 | $2,106 | $17 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 128 | $2,059 | $10 |
| Blood test, comprehensive group of blood chemicals | 96 | $1,945 | $14 |
| Insertion of needle into vein for collection of blood sample | 167 | $906 | $3 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 75 | $549 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 37 | $509 | $13 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 15 | $456 | $25 |
| Urinalysis, manual test | 78 | $367 | $3 |
| Injection, ceftriaxone sodium, per 250 mg | 60 | $365 | None |
| Inhalation treatment for airway obstruction or sputum production | 18 | $276 | $15 |
| Automated urinalysis test | 45 | $151 | $3 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 17 | $131 | None |
| Injection, ketorolac tromethamine, per 15 mg | 33 | $66 | None |
| Infusion, normal saline solution , 1000 cc | 32 | $57 | None |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 43 | $57 | None |
| Infusion, normal saline solution, 250 cc | 40 | $25 | None |
| Injection, ondansetron hydrochloride, per 1 mg | 15 | $8 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 12 | $5 | None |
| Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 15 | $2 | None |
2016: 17 services
| Short return visit (20+ min) | 137 | $15,409 | $56 |
| New patient visit (30+ min) | 181 | $13,876 | $77 |
| Return visit (30+ min) | 50 | $9,118 | $80 |
| New patient visit (45+ min) | 54 | $6,872 | $127 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 50 | $5,953 | $58 |
| Injection of drug or substance under skin or into muscle | 101 | $2,276 | $20 |
| Infusion into a vein for hydration, 31-60 minutes | 20 | $1,256 | $48 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 76 | $1,225 | $10 |
| Blood test, comprehensive group of blood chemicals | 64 | $1,156 | $14 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 74 | $588 | None |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 13 | $487 | $26 |
| Insertion of needle into vein for collection of blood sample | 58 | $297 | $3 |
| Urinalysis, manual test | 55 | $276 | $3 |
| Injection, ceftriaxone sodium, per 250 mg | 46 | $241 | None |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 13 | $95 | None |
| Injection, ketorolac tromethamine, per 15 mg | 21 | $41 | None |
| Infusion, normal saline solution , 1000 cc | 11 | $22 | None |
2015: 7 services
| New patient visit (30+ min) | 46 | $3,688 | $80 |
| Return visit (30+ min) | 16 | $2,870 | $87 |
| Short return visit (20+ min) | 32 | $2,707 | $58 |
| New patient visit (45+ min) | 15 | $1,865 | $124 |
| Injection of drug or substance under skin or into muscle | 20 | $460 | $21 |
| Insertion of needle into vein for collection of blood sample | 16 | $103 | $3 |
| Injection, ceftriaxone sodium, per 250 mg | 12 | $49 | None |
2013: 1 service
| Emergency department visit with low level of medical decision making | 13 | $586 | $45 |
Medicaid work
$7,397 in 2022
Medicaid paid $7,397 for 75 billed services this clinician did in 2022, up to 30 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | 18 | $3,718 |
| New patient visit (60+ min) | 27 | $2,094 |
| Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour | 30 | $1,585 |
| 2022 | 75 | 3 | 30 | $7,397 |
| 2018 | 6,807 | 22 | 479 | $172,247 |
See the largest Medicaid services in earlier years
2018
| New patient visit (30+ min) | 934 | $60,788 |
| New patient visit (45+ min) | 429 | $33,547 |
| Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour | 278 | $19,555 |
| MEASURE BLOOD OXYGEN LEVEL | 1,812 | $11,313 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 1,240 | $9,547 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 335 | $7,073 |
| Injection, ceftriaxone sodium, per 250 mg | 260 | $6,876 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 181 | $5,469 |
| Injection, ondansetron hydrochloride, per 1 mg | 163 | $4,963 |
| Injection, ketorolac tromethamine, per 15 mg | 123 | $2,386 |
| Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure breathing (IPPB) device | 182 | $2,299 |
| Short return visit (20+ min) | 72 | $1,996 |
Drugs they prescribed that Part D paid
$24,810
Pharmacies billed $24,810 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 5% of their Part D prescriptions (134 of 2,460) in 2024. At or below the middle of the specialty; the typical emergency medicine clinician is at 12%.
2,343 generic and fewer than 11 brand-name prescriptions · $24,810 in drug cost · 965 antibiotic prescriptions to 713 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Azithromycin | 278 | $1,173 | $4 |
| Amoxicillin-Clavulanate Potass | 124 | $1,157 | $9 |
| Sulfamethoxazole-Trimethoprim | 214 | $910 | $4 |
| Ofloxacin | 47 | $869 | $17 |
| Fluocinolone Acetonide | 17 | $775 | $41 |
See all 28 drugs
| Azithromycin | 278 | $1,173 | $4 |
| Amoxicillin-Clavulanate Potass | 124 | $1,157 | $9 |
| Sulfamethoxazole-Trimethoprim | 214 | $910 | $4 |
| Ofloxacin | 47 | $869 | $17 |
| Fluocinolone Acetonide | 17 | $775 | $41 |
| Promethazine-Dm | 70 | $710 | $10 |
| Ibuprofen | 161 | $637 | $4 |
| Prednisone | 273 | $626 | $2 |
| Hydrocodone-Acetaminophen | 109 | $575 | $5 |
| Benzonatate | 66 | $489 | $7 |
| Albuterol Sulfate Hfa | 17 | $472 | $26 |
| Nitrofurantoin Mono-Macro | 23 | $455 | $15 |
| Cephalexin | 58 | $422 | $7 |
| Doxycycline Monohydrate | 33 | $375 | $10 |
| Ondansetron Odt | 53 | $348 | $6 |
| Naproxen | 77 | $347 | $4 |
| Ciprofloxacin | 72 | $320 | $4 |
| Omeprazole | 15 | $184 | $11 |
| Fluticasone Propionate | 17 | $165 | $9 |
| Clindamycin | 16 | $162 | $10 |
| Triamcinolone Acetonide | 11 | $122 | $11 |
| Levofloxacin | 11 | $101 | $8 |
| Amlodipine Besylate | 18 | $91 | $4 |
| Fluconazole | 16 | $77 | $4 |
| Cyclobenzaprine | 31 | $53 | $2 |
| Furosemide | 26 | $52 | $1 |
| Meclizine | 13 | $44 | $3 |
| Tramadol | 15 | $34 | $2 |
Year by year
| 2024 | 2,460 | 1,085 | 5% (134) | None | $24,810 |
| 2023 | 2,616 | 1,097 | 7% (176) | 2% | $35,365 |
| 2022 | 1,908 | 858 | 9% (162) | 4% | $31,580 |
| 2021 | 1,559 | 709 | 12% (181) | None | $18,923 |
| 2020 | 1,420 | 610 | 10% (135) | 6% | $24,360 |
| 2019 | 1,756 | 780 | 9% (153) | None | $31,074 |
| 2018 | 1,487 | 668 | 9% (134) | None | $24,591 |
| 2017 | 1,474 | 603 | 10% (148) | 7% | $25,766 |
| 2016 | 1,201 | 414 | 13% (151) | None | $31,457 |
| 2015 | 472 | 182 | 18% (85) | None | $12,353 |
| 2014 | 134 | 35 | 14% (19) | 14% | $5,178 |
| 2013 | 1,523 | 243 | 3% (52) | 16% | $64,882 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 35 drugs
| Azithromycin | 370 | $3,122 | $8 |
| Sulfamethoxazole-Trimethoprim | 284 | $2,112 | $7 |
| Amoxicillin-Clavulanate Potass | 107 | $1,509 | $14 |
| Fluocinolone Acetonide | 32 | $1,320 | $41 |
| Ofloxacin | 56 | $1,177 | $21 |
| Prednisone | 379 | $1,161 | $3 |
| Ibuprofen | 169 | $1,087 | $6 |
| Benzonatate | 71 | $1,024 | $14 |
| Doxycycline Monohydrate | 52 | $980 | $19 |
| Nitrofurantoin Mono-Macro | 36 | $979 | $27 |
| Promethazine-Dm | 79 | $938 | $12 |
| Hydrocodone-Acetaminophen | 145 | $873 | $6 |
| Valacyclovir | 15 | $584 | $39 |
| Albuterol Sulfate Hfa | 17 | $554 | $33 |
| Cephalexin | 46 | $502 | $11 |
| Ondansetron Odt | 33 | $487 | $15 |
| Naproxen | 79 | $473 | $6 |
| Ciprofloxacin | 63 | $453 | $7 |
| Acyclovir | 18 | $358 | $20 |
| Penicillin V | 20 | $235 | $12 |
| Clindamycin | 11 | $218 | $20 |
| Fluticasone Propionate | 12 | $205 | $17 |
| Omeprazole | 13 | $175 | $13 |
| Lisinopril | 14 | $156 | $11 |
| Fluconazole | 11 | $155 | $14 |
| Amlodipine Besylate | 18 | $125 | $7 |
| Levofloxacin | 11 | $120 | $11 |
| Tramadol | 29 | $119 | $4 |
| Metronidazole | 11 | $117 | $11 |
| Paxlovid (Eua) | 11 | $117 | $11 |
| Cyclobenzaprine | 29 | $112 | $4 |
| Meclizine | 13 | $92 | $7 |
| Chlorhexidine Gluconate | 13 | $86 | $7 |
| Tamsulosin | 12 | $81 | $7 |
| Furosemide | 22 | $38 | $2 |
2022: 34 drugs
| Azithromycin | 219 | $2,028 | $9 |
| Sulfamethoxazole-Trimethoprim | 204 | $1,200 | $6 |
| Amoxicillin-Clavulanate Potass | 66 | $955 | $14 |
| Ofloxacin | 30 | $868 | $29 |
| Prednisone | 259 | $838 | $3 |
| Hydrocodone-Acetaminophen | 131 | $799 | $6 |
| Ibuprofen | 121 | $674 | $6 |
| Oseltamivir Phosphate | 15 | $666 | $44 |
| Doxycycline Monohydrate | 27 | $632 | $23 |
| Fluocinolone Acetonide | 15 | $582 | $39 |
| Valacyclovir | 11 | $561 | $51 |
| Cephalexin | 47 | $497 | $11 |
| Ciprofloxacin | 68 | $464 | $7 |
| Ondansetron Odt | 32 | $461 | $14 |
| Lidocaine Hcl Viscous | 21 | $386 | $18 |
| Naproxen | 66 | $358 | $5 |
| Acyclovir | 21 | $324 | $15 |
| Omeprazole | 17 | $272 | $16 |
| Nitrofurantoin Mono-Macro | 11 | $233 | $21 |
| Metronidazole | 18 | $205 | $11 |
| Fluconazole | 15 | $182 | $12 |
| Benzonatate | 11 | $151 | $14 |
| Promethazine-Dm | 12 | $144 | $12 |
| Meclizine | 20 | $123 | $6 |
| Cyclobenzaprine | 28 | $119 | $4 |
| Tramadol | 23 | $101 | $4 |
| Lisinopril | 17 | $87 | $5 |
| Amoxicillin | 12 | $80 | $7 |
| Furosemide | 28 | $70 | $3 |
| Amlodipine Besylate | 15 | $65 | $4 |
| Metoprolol | 11 | $53 | $5 |
| Alprazolam | 11 | $44 | $4 |
| Gabapentin | 15 | $37 | $2 |
| Hydrochlorothiazide | 12 | $29 | $2 |
2021: 24 drugs
| Azithromycin | 138 | $1,058 | $8 |
| Ofloxacin | 37 | $898 | $24 |
| Hydrocodone-Acetaminophen | 145 | $829 | $6 |
| Sulfamethoxazole-Trimethoprim | 155 | $703 | $5 |
| Amoxicillin-Clavulanate Potass | 63 | $693 | $11 |
| Colchicine | 11 | $664 | $60 |
| Ibuprofen | 135 | $647 | $5 |
| Prednisone | 153 | $492 | $3 |
| Fluocinolone Acetonide | 12 | $431 | $36 |
| Ciprofloxacin | 93 | $397 | $4 |
| Valacyclovir | 11 | $366 | $33 |
| Cephalexin | 47 | $347 | $7 |
| Ondansetron Odt | 18 | $238 | $13 |
| Naproxen | 47 | $234 | $5 |
| Doxycycline Monohydrate | 12 | $209 | $17 |
| Metronidazole | 15 | $160 | $11 |
| Amlodipine Besylate | 21 | $156 | $7 |
| Promethazine-Codeine | 16 | $137 | $9 |
| Omeprazole | 12 | $127 | $11 |
| Furosemide | 25 | $123 | $5 |
| Metoprolol | 11 | $98 | $9 |
| Tramadol | 26 | $75 | $3 |
| Cyclobenzaprine | 22 | $66 | $3 |
| Hydrochlorothiazide | 15 | $38 | $3 |
2020: 20 drugs
| Azithromycin | 139 | $1,273 | $9 |
| Ofloxacin | 41 | $1,085 | $26 |
| Prednisone | 153 | $568 | $4 |
| Hydrocodone-Acetaminophen | 107 | $567 | $5 |
| Amoxicillin-Clavulanate Potass | 43 | $520 | $12 |
| Fluocinolone Acetonide | 12 | $515 | $43 |
| Sulfamethoxazole-Trimethoprim | 98 | $475 | $5 |
| Naproxen | 71 | $388 | $5 |
| Ibuprofen | 73 | $318 | $4 |
| Ciprofloxacin | 67 | $317 | $5 |
| Cephalexin | 47 | $292 | $6 |
| Amlodipine Besylate | 29 | $280 | $10 |
| Atorvastatin | 13 | $271 | $21 |
| Ondansetron Odt | 19 | $264 | $14 |
| Benzonatate | 11 | $135 | $12 |
| Meclizine | 13 | $106 | $8 |
| Lisinopril | 13 | $72 | $6 |
| Amoxicillin | 11 | $69 | $6 |
| Tramadol | 20 | $63 | $3 |
| Furosemide | 14 | $43 | $3 |
2019: 28 drugs
| Azithromycin | 214 | $2,126 | $10 |
| Fluocinolone Acetonide | 19 | $1,235 | $65 |
| Amoxicillin-Clavulanate Potass | 85 | $1,168 | $14 |
| Proair Hfa | 16 | $1,031 | $64 |
| Ofloxacin | 24 | $832 | $35 |
| Sulfamethoxazole-Trimethoprim | 154 | $778 | $5 |
| Ciprofloxacin | 115 | $716 | $6 |
| Prednisone | 203 | $640 | $3 |
| Hydrocodone-Acetaminophen | 111 | $578 | $5 |
| Doxycycline Monohydrate | 24 | $574 | $24 |
| Ibuprofen | 93 | $497 | $5 |
| Naproxen | 67 | $457 | $7 |
| Cephalexin | 41 | $330 | $8 |
| Tramadol | 34 | $307 | $9 |
| Amlodipine Besylate | 37 | $294 | $8 |
| Ondansetron Odt | 16 | $278 | $17 |
| Potassium Chloride | 12 | $254 | $21 |
| Pantoprazole | 12 | $186 | $15 |
| Warfarin | 11 | $173 | $16 |
| Metronidazole | 18 | $167 | $9 |
| Fluconazole | 16 | $162 | $10 |
| Fluticasone Propionate | 14 | $142 | $10 |
| Penicillin V | 12 | $121 | $10 |
| Levofloxacin | 11 | $117 | $11 |
| Meclizine | 12 | $103 | $9 |
| Metoprolol | 18 | $97 | $5 |
| Furosemide | 17 | $68 | $4 |
| Ibu | 16 | $66 | $4 |
2018: 26 drugs
| Azithromycin | 198 | $1,726 | $9 |
| Proair Hfa | 18 | $1,097 | $61 |
| Fluocinolone Acetonide | 23 | $1,013 | $44 |
| Amoxicillin-Clavulanate Potass | 60 | $927 | $15 |
| Sulfamethoxazole-Trimethoprim | 147 | $777 | $5 |
| Ofloxacin | 28 | $676 | $24 |
| Ventolin Hfa | 11 | $617 | $56 |
| Prednisone | 173 | $599 | $3 |
| Hydrocodone-Acetaminophen | 98 | $552 | $6 |
| Ondansetron Odt | 18 | $519 | $29 |
| Ciprofloxacin | 70 | $493 | $7 |
| Polyethylene Glycol 3350 | 17 | $460 | $27 |
| Ibuprofen | 92 | $453 | $5 |
| Doxycycline Monohydrate | 15 | $368 | $25 |
| Potassium Chloride | 16 | $304 | $19 |
| Escitalopram | 19 | $259 | $14 |
| Naproxen | 34 | $251 | $7 |
| Fluticasone Propionate | 16 | $222 | $14 |
| Lidocaine Hcl Viscous | 13 | $219 | $17 |
| Cephalexin | 27 | $192 | $7 |
| Tramadol | 25 | $180 | $7 |
| Amlodipine Besylate | 18 | $149 | $8 |
| Penicillin V | 13 | $108 | $8 |
| Ibu | 15 | $74 | $5 |
| Hydrochlorothiazide | 16 | $64 | $4 |
| Furosemide | 13 | $43 | $3 |
2017: 24 drugs
| Azithromycin | 189 | $1,273 | $7 |
| Prednisone | 199 | $766 | $4 |
| Ventolin Hfa | 14 | $753 | $54 |
| Proair Hfa | 11 | $735 | $67 |
| Amoxicillin-Clavulanate Potass | 59 | $706 | $12 |
| Ofloxacin | 27 | $581 | $22 |
| Hydrocodone-Acetaminophen | 101 | $456 | $5 |
| Sulfamethoxazole-Trimethoprim | 123 | $435 | $4 |
| Tramadol | 38 | $347 | $9 |
| Ibuprofen | 98 | $332 | $3 |
| Ciprofloxacin | 63 | $273 | $4 |
| Fluticasone Propionate | 24 | $252 | $11 |
| Lidocaine Hcl Viscous | 15 | $164 | $11 |
| Cephalexin | 26 | $163 | $6 |
| Omeprazole | 18 | $159 | $9 |
| Ibu | 31 | $128 | $4 |
| Amlodipine Besylate | 11 | $121 | $11 |
| Benazepril | 11 | $116 | $11 |
| Naproxen | 18 | $83 | $5 |
| Amoxicillin | 16 | $77 | $5 |
| Cyclobenzaprine | 15 | $59 | $4 |
| Hydrochlorothiazide | 20 | $57 | $3 |
| Metoprolol | 15 | $50 | $3 |
| Furosemide | 13 | $37 | $3 |
2016: 18 drugs
| Fluocinolone Acetonide | 25 | $1,280 | $51 |
| Hydrocodone-Acetaminophen | 97 | $988 | $10 |
| Azithromycin | 105 | $763 | $7 |
| Tramadol | 45 | $649 | $14 |
| Amoxicillin-Clavulanate Potass | 43 | $571 | $13 |
| Levothyroxine | 21 | $509 | $24 |
| Prednisone | 126 | $502 | $4 |
| Ibuprofen | 91 | $400 | $4 |
| Ciprofloxacin | 61 | $384 | $6 |
| Omeprazole | 25 | $375 | $15 |
| Gabapentin | 15 | $373 | $25 |
| Sulfamethoxazole-Trimethoprim | 78 | $325 | $4 |
| Atorvastatin | 13 | $232 | $18 |
| Metronidazole | 13 | $183 | $14 |
| Naproxen | 21 | $117 | $6 |
| Cephalexin | 17 | $113 | $7 |
| Penicillin V | 11 | $104 | $9 |
| Metoprolol | 12 | $41 | $3 |
2015: 9 drugs
| Hydrocodone-Acetaminophen | 63 | $766 | $12 |
| Amoxicillin-Clavulanate Potass | 21 | $371 | $18 |
| Ibuprofen | 38 | $267 | $7 |
| Levofloxacin | 13 | $243 | $19 |
| Tramadol | 12 | $218 | $18 |
| Sulfamethoxazole-Trimethoprim | 39 | $171 | $4 |
| Azithromycin | 26 | $168 | $6 |
| Ciprofloxacin | 14 | $142 | $10 |
| Prednisone | 22 | $103 | $5 |
2014: 3 drugs
| Hydrocodone-Acetaminophen | 11 | $358 | $33 |
| Doxazosin Mesylate | 13 | $292 | $22 |
| Hydrochlorothiazide | 12 | $34 | $3 |
2013: 37 drugs
| Spiriva | 24 | $6,445 | $269 |
| Lantus | 21 | $5,947 | $283 |
| Crestor | 18 | $3,690 | $205 |
| Metoprolol | 38 | $1,497 | $39 |
| Lisinopril | 117 | $1,201 | $10 |
| Metformin | 87 | $982 | $11 |
| Omeprazole | 71 | $940 | $13 |
| Gabapentin | 19 | $890 | $47 |
| Simvastatin | 71 | $713 | $10 |
| Amlodipine Besylate | 58 | $642 | $11 |
| Losartan | 21 | $640 | $30 |
| Proair Hfa | 12 | $559 | $47 |
| Tamsulosin | 25 | $446 | $18 |
| Gemfibrozil | 12 | $438 | $37 |
| Glyburide | 16 | $393 | $25 |
| Naproxen | 31 | $343 | $11 |
| Glimepiride | 38 | $340 | $9 |
| Hydrochlorothiazide | 73 | $321 | $4 |
| Tramadol | 18 | $315 | $18 |
| Carvedilol | 18 | $313 | $17 |
| Levothyroxine | 27 | $296 | $11 |
| Ibuprofen | 41 | $285 | $7 |
| Alendronate | 15 | $252 | $17 |
| Benazepril | 24 | $250 | $10 |
| Atenolol | 48 | $213 | $4 |
| Finasteride | 16 | $202 | $13 |
| Paroxetine | 18 | $197 | $11 |
| Doxazosin Mesylate | 17 | $181 | $11 |
| Hydrocodone-Acetaminophen | 23 | $166 | $7 |
| Lovastatin | 15 | $149 | $10 |
| Ranitidine | 15 | $140 | $9 |
| Citalopram Hbr | 16 | $126 | $8 |
| Enalapril Maleate | 12 | $102 | $8 |
| Furosemide | 22 | $101 | $5 |
| Cyclobenzaprine | 13 | $92 | $7 |
| Allopurinol | 16 | $83 | $5 |
| Metoprolol | 11 | $47 | $4 |
Money from drug and device companies
$20 in 2025
| 2025 | 1 | 1 | None | $20 |
| 2022 | 1 | 3 | None | $44 |
| 2021 | 2 | 2 | None | $29 |
| 2020 | 1 | 3 | None | $120 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| GlaxoSmithKline | Shingrix | $20 | 1 payment
|
See the published payment
| GlaxoSmithKline | Meals · 2025-06-02 | Shingrix | $20 |
See earlier years (2022, 2021, 2020)
2022: $44
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $44 | 3 payments
|
2021: $29
| Biohaven Pharmaceuticals | Nurtec Odt | $24 | 1 payment
|
| Forte Bio-Pharma | Nalocet | $4 | 1 payment
|
2020: $120
| Si-Bone | Ifuse Implant | $120 | 3 payments
|
Checkups this office reported
20 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 75.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Appropriate Testing for PharyngitisAs Medicare defines this measure | 1% | 379 |
| Appropriate Treatment for Upper Respiratory Infection (URI)As Medicare defines this measure | 20% | 720 |
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 43%That's less than half. | 1,695 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 49%That's less than half. | 561 |
| Breast cancer screeningEligible women who got a mammogram | 15%That's few of the people this applied to. | 1,010 |
| Cervical cancer screeningEligible women who got a Pap or HPV test | 15%That's few of the people this applied to. | 1,767 |
| Checked for fall riskOlder patients screened for fall risk | 0%That's few of the people this applied to. | 1,358 |
| Childhood Immunization StatusAs Medicare defines this measure | 4% | 57 |
See the other 12 measures
| Chlamydia Screening for WomenAs Medicare defines this measure | 29% | 72 |
| Closing the Referral Loop: Receipt of Specialist ReportAs Medicare defines this measure | 1% | 305 |
| Colon cancer screeningEligible adults who got a colon cancer test | 22%That's few of the people this applied to. | 2,086 |
| Depression screeningPatients screened for depression, with a follow-up plan if needed | 1%That's few of the people this applied to. | 4,769 |
| Diabetes eye examPeople with diabetes who got a retinal eye exam | 10%That's few of the people this applied to. | 281 |
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 72%That's more than half. Worse on this measure. | 281 |
| Medications listed in the chartVisits where the current medication list was documented | 67%That's more than half. | 8,619 |
| Patients can see their records onlinePatients who were given electronic access to their health information | 97%That's most of the people this applied to. | 6,052 |
| Prescriptions sent electronicallyPrescriptions sent to the pharmacy by computer instead of paper | 95%That's most of the people this applied to. | 13,746 |
| Risky medications in older adultsOlder patients given a medication that is risky at their age | 8%That's few of the people this applied to. Better on this measure. | 1,427 |
| Screening for High Blood Pressure and Follow-Up DocumentedAs Medicare defines this measure | 24% | 7,566 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 22%That's few of the people this applied to. | 4,909 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Checks the state prescription-drug database before prescribing
- Diabetes screening
- Did a security review of patient data
- Electronic Health Record Enhancements for BH data capture
- Enabling Exchange Under TEFCA
- High Priority Practices Guide of the Safety Assurance Factors for EHR Resilience (SAFER) Guides
- Reports cases to public health electronically
- Reports immunizations to the state registry
- Reports to a public-health or clinical registry
- Tobacco use
Professional record
- NPI
- 1740327568
- Licence
- CA A92203California A92203: Current · expires 2027-01-31
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207QA0505X (207QA0505X)
- Mailing address
- 220 Standiford Ave F, Modesto, CA, 95350
- NPI first listed
- 2007-01-31
- NPI last updated
- 2015-07-16
This is when the NPI record was last certified, not a medical board exam.